Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes

Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes

In previous studies, we developed and characterised multicompartmental microcapsules as a platform for the targeted oral delivery of lipophilic drugs in type 2 diabetes (T2D). We also designed a new microencapsulated formulation of probucol-sodium alginate (PB-SA), with good structural properties an...

Full description

Bibliographic Details
Main Authors: Mooranian, Armin, Negrulj, Rebecca, Al-Sallami, H., Fang, Zhongxiang, Mikov, Momir, Golocorbin-Kon, S., Fakhoury, M., Watts, G., Matthews, V., Arfuso, Frank, Lambros, Amanda, Al-Salami, Hani
Format: Journal Article
Published: AAPS 2014
Subjects:
diabetes mellitus
artificial-cell microencapsulation
anti-inflammatory
probucol
antioxidant
type 2 diabetes
Online Access:http://hdl.handle.net/20.500.11937/5324

Internet

http://hdl.handle.net/20.500.11937/5324

Similar Items